Silicon Hills Wealth Management’s Intellia Therapeutics NTLA Stock Holding History

Silicon Hills Wealth Management’s Portfolio NTLA Stock Details NTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$289K	Hold	7,082	–	–	0.16%	70
2023 Q1	$264K	Sell	7,082 -413	-6%	-$16.2K	0.16%	70
2022 Q4	$262K	Hold	7,495	–	–	0.19%	81
2022 Q3	$419K	Hold	7,495	–	–	0.33%	64
2022 Q2	$388K	Hold	7,495	–	–	0.28%	70
2022 Q1	$545K	Hold	7,495	–	–	0.35%	63
2021 Q4	$886K	Sell	7,495 -1,105	-13%	-$138K	0.55%	51
2021 Q3	$1.15M	Sell	8,600 -20	-0.2%	-$3.03K	0.79%	40
2021 Q2	$1.4M	Buy	8,620 +107	+1%	+$8.33K	1.08%	29
2021 Q1	$683K	Hold	8,513	–	–	0.62%	50
2020 Q4	$463K	Buy	+8,513	New	+$309K	0.42%	53

Other funds holding NTLA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Silicon Hills Wealth Management's NTLA Position: Q2 2023 in Review

Silicon Hills Wealth Management held its Intellia Therapeutics (NTLA) position steady in Q2 2023 at 7,082 shares worth $289K. The position accounts for 0.16% of the portfolio, ranked #70.

Silicon Hills Wealth Management first reported a position in NTLA in Q4 2020 and has held it in 11 quarters since. The position peaked at $1.4M in Q2 2021. 290 funds tracked by Wall St. Rank hold NTLA as of Q2 2023.

Silicon Hills Wealth Management held 7,082 shares of Intellia Therapeutics worth $289K as of Q2 2023.
Silicon Hills Wealth Management left its Intellia Therapeutics share count unchanged in Q2 2023.
Intellia Therapeutics made up 0.16% of Silicon Hills Wealth Management's portfolio in Q2 2023, its #70 holding.
Silicon Hills Wealth Management first reported a position in Intellia Therapeutics in Q4 2020 and has held it in 11 quarters since.
Silicon Hills Wealth Management's Intellia Therapeutics position peaked at $1.4M in Q2 2021.
290 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2023.

Based on Silicon Hills Wealth Management's 13F filing for Q2 2023, filed 14 Aug 2023.